Cargando…
Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805830/ https://www.ncbi.nlm.nih.gov/pubmed/36597467 http://dx.doi.org/10.1155/2022/9808495 |
| _version_ | 1784862414430273536 |
|---|---|
| author | International, BioMed Research |
| author_facet | International, BioMed Research |
| author_sort | International, BioMed Research |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9805830 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98058302023-01-02 Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis International, BioMed Research Biomed Res Int Retraction Hindawi 2022-12-25 /pmc/articles/PMC9805830/ /pubmed/36597467 http://dx.doi.org/10.1155/2022/9808495 Text en Copyright © 2022 BioMed Research International. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction International, BioMed Research Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| title | Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| title_full | Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| title_fullStr | Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| title_full_unstemmed | Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| title_short | Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| title_sort | retracted: clinical efficacy and safety analysis of pd-1/pd-l1 inhibitor vs. chemotherapy in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805830/ https://www.ncbi.nlm.nih.gov/pubmed/36597467 http://dx.doi.org/10.1155/2022/9808495 |
| work_keys_str_mv | AT internationalbiomedresearch retractedclinicalefficacyandsafetyanalysisofpd1pdl1inhibitorvschemotherapyinthetreatmentofadvancednonsmallcelllungcancerasystematicreviewandmetaanalysis |